J P Vandenbroucke
Overview
Explore the profile of J P Vandenbroucke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
355
Citations
5510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sogaard M, Heide-Jorgensen U, Vandenbroucke J, Schonheyder H, Vandenbroucke-Grauls C
Clin Microbiol Infect
. 2017 Apr;
23(12):952-960.
PMID: 28377310
Objective: To verify the role of proton pump inhibitors (PPI) and nitrofurantoin, which have appeared as novel risk factors for carriage of extended-spectrum β-lactamase (ESBL) -producing Escherichia coli, as risk...
2.
van Helvoort T, Vandenbroucke J
Ned Tijdschr Geneeskd
. 2016 Jun;
160:D116.
PMID: 27299492
Medical researchers and physicians are not trained in the care of their written or digital past. Here, a scientific historian and a clinical epidemiologist reflect on possibilities for archiving the...
3.
4.
Pomp E, van Stralen K, le Cessie S, Vandenbroucke J, Rosendaal F, Doggen C
Eur J Epidemiol
. 2010 Jun;
25(7):459-66.
PMID: 20549310
We discuss the analytic and practical considerations in a large case-control study that had two control groups; the first control group consisting of partners of patients and the second obtained...
5.
Dekkers O, Romijn J, de Boer A, Vandenbroucke J
Pituitary
. 2009 Dec;
13(3):195-8.
PMID: 20012697
The question has been raised whether hyperprolactinemia in humans is associated with an excess risk for breast cancer. We aimed to assess the risk of breast cancer in a previously...
6.
van Hylckama Vlieg A, Helmerhorst F, Vandenbroucke J, Doggen C, Rosendaal F
BMJ
. 2009 Aug;
339:b2921.
PMID: 19679614
Objective: To assess the thrombotic risk associated with oral contraceptive use with a focus on dose of oestrogen and type of progestogen of oral contraceptives available in the Netherlands. Design:...
7.
de Rooij A, Vandenbroucke J, Smit J, Stokkel M, Dekkers O
Eur J Endocrinol
. 2009 Aug;
161(5):771-7.
PMID: 19671708
Background: Despite the long experience with radioiodine for hyperthyroidism, controversy remains regarding the optimal method to determine the activity that is required to achieve long-term euthyroidism. Objectives: To compare the...
8.
Kars M, Souverein P, Herings R, Romijn J, Vandenbroucke J, de Boer A, et al.
J Clin Endocrinol Metab
. 2009 Jun;
94(8):2729-34.
PMID: 19491225
Context: Few data exist on sex- and age-specific incidence and prevalence of idiopathic hyperprolactinemia and prolactinomas. Objectives: Our objective was to assess incidence and prevalence of dopamine agonist-treated hyperprolactinemia by...
9.
Dekkers O, von Elm E, Algra A, Romijn J, Vandenbroucke J
Int J Epidemiol
. 2009 Apr;
39(1):89-94.
PMID: 19376882
Background: External validity of study results is an important issue from a clinical point of view. From a methodological point of view, however, the concept of external validity is more...
10.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J
Internist (Berl)
. 2008 May;
49(6):688-93.
PMID: 18511988
Much of biomedical research is observational. The reporting of such research is often inadequate, which hampers the assessment of its strengths and weaknesses and of a study's generalizability. The Strengthening...